Quality management in surgical intervention - A prospective outcomes research study of fleece-bound tissue gluing (TachoSil®);Qualitätsmanagement in der chirurgischen intervention - Eine prospektive versorgungsforschungsstudie zu vliesgebundener gewebeklebung (TachoSil®)

Gesundheitsokonomie und Qualitatsmanagement

Volumn 10, Issue 3, 2005, Pages 151-160

  Kallinowski, Friedrich ^a   Pfeil, T ^b   Ulbrich, W ^b  

^a Academic Teaching Hospital of the Universities of Kiel   (Germany)

^b Nycomed Pharma Deutschland GmbH   (Germany)

Author keywords

Costs; Fleece gluing; Surgery; TachoSil; Tissue management

Indexed keywords

TACHOCOMB; TACHOSIL; TISSUE ADHESIVE;

ARTICLE; BLOOD TRANSFUSION; COST BENEFIT ANALYSIS; COST CONTROL; FEMALE; GERMANY; HEALTH CARE QUALITY; HOSPITAL; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; OPEN STUDY; OPERATION DURATION; OUTCOMES RESEARCH; PROSPECTIVE STUDY; RESOURCE MANAGEMENT; SURGICAL INJURY;

EID: 22244441135     PISSN: 14322625     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2005-858229     Document Type: Article

References (18)

1. Mankad PS, Codispoti M. The role of fibrin sealants in hemostasis. Am J Surg 2001; 182 (Suppl 2): 21S-28S
2. Gassel HJ. Gewebeklebung in der hepato-pankreatiko-biliären Chirurgie: klinische Erfahrungen und Perspektiven. In: Thiede A, Roewer N, Elert O, Riedmiller H (Hrsg). Zentrum operative Medizin - Chronik und Vision. Ravensburg: CICI, 2004: 239
3. Carbon RT. Evaluation of biodegradable fleece-bound sealing: history, material science, and clinical application. In: Lewandrowski K, Wise DL, Trantolo DJ, Gresser JD, Yascemski ML, Altobelli DE (Hrsg). Tissue engineering and biodegradable equivalents: Scientific and clinical applications. New York: Marcel Dekker Inc. 2002: 587-650
4. Schiele U, Kuntz G, Riegler A. Fixed combination of fibrin glue with a sheet of collagen. A ready-to-use local haemostyptic agent. Surgical Technology International 1991; 1: 120-124
5. Hollaus P, Pridun N. The use of TachoComb® in thoracic surgery. J Cardiovasc Surg 1994; 35: 169-170
6. Frilling A, Stavrou G, Mischinger HJ et al. Effectiveness of TachoComb® S versus argon beamer as hemostatic agent during liver resection: A randomized prospective trial. Langenbecks Archives of Surgery 2005; 390: 114-120
7. Lang G, Csekeö A, Stamatis G et al. Efficacy and safety of topical application of human fibrinogen/thrombin-coated collagen patch (TachoComb) for treatment of air leakage after standard lobectomy. European Journal of Cardio-thoracic Surgery 2004; 25: 160-166
8. Czerny M, Verrel F, Weber H et al. Collagen patch coated with fibrin glue components - Treatment of suture hole bleedings in vascular reconstruction. J Cardiovasc Surg 2000; 41: 553-557
9. Czerny M, Fleck T, Salat A et al. Sealing the mediastimun with a local hemostyptic agent reduces chest tube duration after complete mediastinal lymph node dissection for stage I and II non-small cell lung cancer. Ann Thorac Surg 2004; 77: 1028-1032
10. www.g-drg.de, Zugriff am 1.12.2004
11. Sozialgesetzbuch V: Gesetzliche Krankenversicherung. München: Beck Juristischer Verlag, 2004
12. Rychlik R. Gesundheitsökonomie. Stuttgart: Enke, 1999: 48-49
13. Greiner W. Die Berechnung von Kosten und Nutzen im Gesundheitswesen. In: Schöffski O, Glaser P, Graf von der Schulenburg JM (Hrsg). Gesundheitsökonomische Evaluationen. Berlin: Springer, 1999: 74-75
14. Deutsche Krankenhausgesellschaft (http://www.dkgev.de). Krankenhausbarometer, Umfrage 2003. http://dkg.digramm.com/pdf/255.pdf, Zugriff am 3.12.2004.
15. Miller DA. Overview of medical device regulations and their impact on new technology in orthopedics. American Academy of Orthopaedic Surgeons Academic, Industry and Federal Interactions in Developing and Applying New Technology for Orthopaedics 1999. http://www3.aaos.org/technology/miller.cfm, Zugriff am 15.12.2004.
16. Deutsche Krankenhausgesellschaft. DKG-NT Band 1. München: Kohlhammer, 2002
17. Schleppers A, Sturm J, Bender HJ. Implementierung einer Geschäftsführung für ein zentrales OP-Management - Öl oder Sand im Getriebe des OP-Ablaufes. Anästhesiologie und Intensivmedizin 2003; 44: 295-303
18. Macario A, Vitez TS, Dunn B et al. Where are the costs in perioperative care? Analysis of hospital costs and charges of inpatient surgical care. Anaesthesiology 1995; 83: 1138-1144